CytoDyn
CytoDyn is developing leronlimab (PRO 140), a potential drug to treating COVID-19. Now undergoing clinical trials with the FDA.
Rankings by 
Национальный рейтинг
244th
in United StatesРегиональный рейтинг
272nd
in North America and CaribbeanГлобальный рейтинг
667th
worldwide